Stay updated on TEPEZZA Post-Marketing Requirement Study Clinical Trial
Sign up to get notified when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.

Latest updates to the TEPEZZA Post-Marketing Requirement Study Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the 403 error page, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1. The page otherwise remains a 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error message, replacing the study record content with a generic header/footer. The main content and related links have been removed, leaving only site chrome and the error notice.SummaryDifference19%

- Check40 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, signaling a version update of the page template/system. This change reflects an update to the page framework rather than a modification to study data or content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a newer document version. This is a metadata change that does not alter the study details or visible content.SummaryDifference0.0%

- Check61 days agoChange DetectedAdministrative dates for certification/extension postings were updated in the study record. This reflects record-keeping changes rather than any modification to the trial design, eligibility criteria, or participant access.SummaryDifference0.4%

Stay in the know with updates to TEPEZZA Post-Marketing Requirement Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.